Modest growth in revenue despite lack of profitability may be driving share price increase. Signs of growth acceleration and insider buying warrant closer attention.
Gainers: •$Rocket Pharmaceuticals(RCKT.US)$+10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy) •$加拿大鵝(GOOS.US)$+9.4% (the company reported an unexpected profit as well as better-than-expected revenue) •$SIGA Technologies(SIGA.US)$+6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...
TIPSY樓主 : 10%收工